NCT07099196 is a NA clinical trial of Headset-based Virtual Reality Simulation in Thalassemia, Beta, sponsored by Mohammed Bin Rashid University of Medicine and Health Sciences.

Who is sponsoring NCT07099196?

NCT07099196 is sponsored by Mohammed Bin Rashid University of Medicine and Health Sciences.

What drugs are being tested in NCT07099196?

Interventions in NCT07099196: Headset-based Virtual Reality Simulation.

What condition does NCT07099196 study?

NCT07099196 studies Thalassemia, Beta, Thalassemia, Pain, Anxiety, Blood Disorder.

Is NCT07099196 still recruiting?

NCT07099196 is currently completed. Last updated 1 August 2025.

Last reviewed 2025-08-01 · How we verify

NCT07099196

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE.

Completed NA Last updated 1 August 2025

What this trial tests

NA trial testing Headset-based Virtual Reality Simulation in Thalassemia, Beta in 115 participants. Completed in 20 August 2024.

Timeline

24 May 2024

Primary endpoint
20 August 2024

20 August 2024

Quick facts

Lead sponsor	Mohammed Bin Rashid University of Medicine and Health Sciences
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	115
Start date	24 May 2024
Primary completion	20 August 2024
Estimated completion	20 August 2024
Sites	1 location across United Arab Emirates

Drugs / interventions tested

Headset-based Virtual Reality Simulation

Conditions studied

Thalassemia, Beta — all drugs for Thalassemia, Beta →
Thalassemia — all drugs for Thalassemia →
Pain — all drugs for Pain →
Anxiety — all drugs for Anxiety →

Sponsor

Mohammed Bin Rashid University of Medicine and Health Sciences

Who can join

7 and older, any sex, with Thalassemia, Beta or Thalassemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this trial is to evaluate the effects of therapeutic Virtual Reality (VR) on pain, anxiety, fatigue and boredom during intravenous (IV) cannulations in comparison to standard of care (SOC).The main question it aims to answer is whether VR can act as an adjuvant for the IV cannulation procedure and improve overall patient experience. Questionnaires were completed after the intravenous cannulation procedure during visits 1, 2 and 3. The Visual Analogue Scale (VAS) was used to assess both primary (pain and anxiety) and secondary (fatigue and boredom) objectives, collecting self-reported data during the three visits. Heart Rate (measured in beats per minute (BPM)) and Blood Pressure (measured in millimeters of mercury (mmHg)) were measured after each procedure * Participants will come for their routine cannulation and be recruited if willing * Participants carry out the SOC procedure and are asked to fill out the questionnaires after * The procedure is carried out with VR at the next appointment after 3-4 weeks * This is repeated in the next visit

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in the UAE: A Crossover Clinical Trial
Khan SA, Mohammed FS, Rathore HI, Soliman A, et al · · 2025 · DOI 10.21203/rs.3.rs-7539274/v1

Verify or expand the search:

Other recruiting trials for Thalassemia, Beta

Currently open trials in the same condition.

NCT06041620 — Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells · NA · recruiting
NCT05736419 — A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an · Phase 2 · recruiting
NCT06314529 — Long-term Follow-up Study of BHC001 for TDT · recruiting
NCT05799118 — Study of the Role of Genetic Modifiers in Hemoglobinopathies · recruiting

Other Mohammed Bin Rashid University of Medicine and Health Sciences trials

Trials by the same sponsor.

NCT07073196 — Single Implant Crowns Supported by Narrow or Standard Diameter Implants in Molar Sites · NA · recruiting
NCT07377890 — Accuracy of Digital vs Conventional Denture Impressions: An In Vivo Study · NA · recruiting
NCT07184346 — Accuracy of Centric Relation Recording: Conventional to Optical · NA · not yet recruiting
NCT07164066 — Digital vs Conventional Prosthetic Rehab & Occlusal Analysis in Edentulous Patients · NA · not yet recruiting
NCT06808854 — Variable-thread Versus Standard Dental Implants for Replacing Missing Teeth · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07099196 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mohammed Bin Rashid University of Medicine and Health Sciences
Last refreshed: 1 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07099196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing